Form 8-K · Current Report · Filed 2025-05-13
Stryker Corporation Shareholder Approval of Incentive Plans and Annual Meeting Voting Results
On May 8, 2025, Stryker Corporation's shareholders approved an increase in the number of shares available for issuance under the 2011 Long-Term Incentive Plan, the 2011 Performance Incentive Award Plan, and the 2008 Employee Stock Purchase Plan.
- Filer
- Stryker Corporation SYK · NYSE
- Filed
- Accession
- 0000310764-25-000085
- CIK
- 0000310764
- Signal
- High impactHealthcare
- Source
- Official filing on sec.gov ↗
Details
The shareholders also elected all ten directors to serve until the next Annual Meeting and ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for 2025. An advisory vote on the compensation of named executive officers was also approved.
Items reported
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
Submission of Matters to a Vote of Security Holders
Market reaction
Close before filing
$388.08
Next session
-0.5%
Since filing
-16.1%
Latest close
$325.70
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from SYK reporting the same item, with the next session's move:
About Stryker Corporation
Stryker Corporation is a prominent player in the medical technology industry, known for its innovative solutions across healthcare sectors such as orthopedics, medical and surgical, and neurotechnology and spine. The company's purpose is to enhance patient care through its wide array of products, including surgical equipment and advanced medical devices. Stryker plays a critical role in the healthcare market by providing essential tools and technologies that assist in improving surgical precision and patient recovery processes. With a continuous focus on research and development, Stryker Corporation remains at the forefront of medical advancements, directly impacting hospitals, surgical centers, and healthcare providers globally. The company's extensive distribution network and partnerships with medical professionals ensure that its technologies contribute to improving health outcomes across diverse geographical regions.
Never miss another SYK filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.